<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01287026</url>
  </required_header>
  <id_info>
    <org_study_id>110091</org_study_id>
    <secondary_id>11-H-0091</secondary_id>
    <nct_id>NCT01287026</nct_id>
  </id_info>
  <brief_title>Real-time MRI Right Heart Catheterization Using Passive Catheters</brief_title>
  <official_title>Real-Time MRI Right Heart Catheterization Using Passive Catheters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      - Currently, heart catheterization procedures are guided by X-rays. Researchers are&#xD;
      developing new techniques to perform heart catheterization without the use of X-rays by&#xD;
      investigating possible uses of magnetic resonance imaging (MRI) scans. To study these uses,&#xD;
      researchers are interested in performing a part of the standard X-ray catheterization&#xD;
      procedure using MRI on individuals who are scheduled to have heart catheterization.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      - To examine the safety and feasibility of right-heart catheterization using MRI-guided&#xD;
      catheters.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
      - Individuals at least 21 years of age who are undergoing a medically necessary heart&#xD;
      catheterization procedure.&#xD;
&#xD;
      Design:&#xD;
&#xD;
        -  The research MRI procedure will be performed either before or after standard X-ray&#xD;
           guided heart catheterization.&#xD;
&#xD;
        -  Participants will be transferred from an X-ray table onto an MRI table and advanced into&#xD;
           the scanner. Under MRI guidance, a MRI-compatible catheter will be used to measure blood&#xD;
           pressure and blood oxygen levels in the heart, and MRI scanning will be performed for&#xD;
           approximately 30 minutes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart catheterization is a minimally invasive procedure to measure pressure and inject dye&#xD;
      into specific heart cavities. Heart catheterization usually uses X-ray guidance, which&#xD;
      involves radiation exposure and which fails to visualize soft tissue.&#xD;
&#xD;
      We have developed real-time magnetic resonance imaging (MRI) to guide heart catheterization&#xD;
      with tissue visualization but without X-ray radiation. In the first phase of this protocol we&#xD;
      showed that comprehensive right-sided heart catheterization is feasible in adult patients,&#xD;
      using commercially available MRI-compatible ( passive ) catheters.&#xD;
&#xD;
      In the second phase of the protocol, we began performing systematic right-sided heart&#xD;
      catheterization without X-ray whenever possible. We will assess the hearts response to&#xD;
      hemodynamic provocation during MRI catheterization tailored to the patient s problem. We will&#xD;
      use this protocol to further refine the technique&#xD;
&#xD;
      If successful, this will enable future testing of devices for adult and pediatric MRI-guided&#xD;
      catheterization, such as special active wire guides, which may lead to new non-surgical&#xD;
      treatments of cardiovascular disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 23, 2011</start_date>
  <completion_date type="Actual">March 21, 2019</completion_date>
  <primary_completion_date type="Actual">March 21, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To test the initial safety and feasibility of diagnostic right heart catheterization in human subjects using MRI- guidance and</measure>
    <time_frame>Ongoing</time_frame>
    <description>There will be no heating or adverse events related to the MRI RHC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To train staff in the conduct of simple MRI catheterization in humans, to accrue incremental experience towards more complex MRI catheterization procedures</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To test incremental MRI scanning techniques (technical developments) to assist MRI catheterization in humans</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Caridovascular Disease</condition>
  <condition>Congenital Heart Disease</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open Label</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac Real-time MRI RHC (Right Heart Catheterization)</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        Age greater than or equal to 2 years old&#xD;
&#xD;
        Undergoing medically necessary diagnostic or interventional right and/or left&#xD;
        cardiovascular catheterization&#xD;
&#xD;
        EXCLUSION CRITERIA :&#xD;
&#xD;
        Cardiovascular instability including ongoing acute myocardial infarction, refractory angina&#xD;
        or ischemia, and decompensated congestive heart failure.&#xD;
&#xD;
        Women who are pregnant or nursing&#xD;
&#xD;
        Unable to undergo magnetic resonance imaging:&#xD;
&#xD;
          -  Cardiac pacemaker or implantable defibrillator&#xD;
&#xD;
          -  Cerebral aneurysm clip&#xD;
&#xD;
          -  Neural stimulator (e.g. TENS-Unit)&#xD;
&#xD;
          -  Any type of ear implant&#xD;
&#xD;
          -  Ocular foreign body (e.g. metal shavings)&#xD;
&#xD;
          -  Metal shrapnel or bullet.&#xD;
&#xD;
          -  Any implanted device (e.g. insulin pump, drug infusion device), unless it is labeled&#xD;
             safe for MRI&#xD;
&#xD;
        EXCLUSION CRITERIA FOR GADOLINIUM-BASED CONTRAST AGENTS FOR ADULTS:&#xD;
&#xD;
        Renal excretory dysfunction, estimated glomerular filtration rate &lt; 30 mL/min/1.73m(2) body&#xD;
        surface area according to the Modification of Diet in Renal Disease criteria&#xD;
&#xD;
        Glomerular filtration rate will be estimated using the CKD-EPI equation (33):&#xD;
&#xD;
        eGFR equal 141 x (minimum of (Scr/K, 1)(a) x (maximum of (Scr/K, 1)) (-1.209) x 0.993(Ag x&#xD;
        1.018 (if female) x 1.159 (if black)&#xD;
&#xD;
        Where&lt;TAB&gt;Scr equal serum creatinine&#xD;
&#xD;
        a = -0.329 for females and -0.411 for males&#xD;
&#xD;
        k = 0.7 for females and 0.9 for males&#xD;
&#xD;
        Subjects meeting this exclusion criterion may still be included in the study but may not be&#xD;
        exposed to gadolinium-based contrast agents.&#xD;
&#xD;
        EXCLUSION CRITERIA FOR GADOLINIUM-BASED CONTRAST AGENTS FOR CHILDREN&#xD;
&#xD;
        Renal excretory dysfunction, estimated glomerular filtration rate &lt; 30 mL/min/1.73m(2) body&#xD;
        surface area according to the Schwartz equation for estimation of GFR in children as&#xD;
        recommended by the National Kidney Disease Education Program. The Schwartz equation is&#xD;
        commonly used for GFR determination in children at Children s National Medical Center,&#xD;
        Washington, DC.&#xD;
&#xD;
        GFR (mL/min/1.73 m2) = (k (SqrRoot) height) / serum creatinine concentration where K =&#xD;
        constant defined as&#xD;
&#xD;
        follows:&#xD;
&#xD;
        k = 0.33 in premature infants [Excluded from this protocol]&#xD;
&#xD;
        k = 0.45 in term infants to 1 year of age [Excluded from this protocol]&#xD;
&#xD;
        k = 0.55 in children to 13 years of age&#xD;
&#xD;
        k = 0.70 in adolescent males (not females because of the presumed increase in male muscle&#xD;
        mass,&#xD;
&#xD;
        the constant remains 0.55 for females)&#xD;
&#xD;
          -  Height in cm&#xD;
&#xD;
          -  Serum creatinine in mg/dL&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert J Lederman, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart, Lung, and Blood Institute (NHLBI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 21, 2019</verification_date>
  <study_first_submitted>January 25, 2011</study_first_submitted>
  <study_first_submitted_qc>January 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2011</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MRI Catheterization</keyword>
  <keyword>Right Heart Catheterization</keyword>
  <keyword>Pulmonary Artery Catheterization</keyword>
  <keyword>MRI Safety</keyword>
  <keyword>Jugular Vein Catheterization</keyword>
  <keyword>Heart Catheterization</keyword>
  <keyword>Heart Disease</keyword>
  <keyword>Cardiovascular Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

